Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxium for grade 1 to 3 varicose veins
IRCT20250718066534N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of calcium dobesilate in Varicose Veins (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Symptom Score. Started Aug 2025; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on IRCT20250718066534N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250718066534N1.